These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 17453711)
1. Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice. Fredrikson GN; Lindholm MW; Ljungcrantz I; Söderberg I; Shah PK; Nilsson J Autoimmunity; 2007 Mar; 40(2):122-30. PubMed ID: 17453711 [TBL] [Abstract][Full Text] [Related]
2. Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies. Fredrikson GN; Björkbacka H; Söderberg I; Ljungcrantz I; Nilsson J J Intern Med; 2008 Dec; 264(6):563-70. PubMed ID: 18783480 [TBL] [Abstract][Full Text] [Related]
6. Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression. Fredrikson GN; Andersson L; Söderberg I; Dimayuga P; Chyu KY; Shah PK; Nilsson J Autoimmunity; 2005 Mar; 38(2):171-9. PubMed ID: 16040338 [TBL] [Abstract][Full Text] [Related]
7. Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease. Dunér P; To F; Alm R; Gonçalves I; Fredrikson GN; Hedblad B; Berglund G; Nilsson J; Bengtsson E J Intern Med; 2009 May; 265(5):593-603. PubMed ID: 19226376 [TBL] [Abstract][Full Text] [Related]
8. Immunization of LDL receptor-deficient mice with beta2-glycoprotein 1 or human serum albumin induces a more inflammatory phenotype in atherosclerotic plaques. Dunoyer-Geindre S; Kwak BR; Pelli G; Roth I; Satta N; Fish RJ; Reber G; Mach F; Kruithof EK; de Moerloose P Thromb Haemost; 2007 Jan; 97(1):129-38. PubMed ID: 17200780 [TBL] [Abstract][Full Text] [Related]
9. Oxidation of low-density lipoprotein cholesterol following administration of poloxamer 407 to mice results from an indirect effect. Johnston TP; Zhou X J Cardiovasc Pharmacol; 2007 Apr; 49(4):246-52. PubMed ID: 17438410 [TBL] [Abstract][Full Text] [Related]
10. Sequence, structure, receptor-binding domains and internal repeats of human apolipoprotein B-100. Yang CY; Chen SH; Gianturco SH; Bradley WA; Sparrow JT; Tanimura M; Li WH; Sparrow DA; DeLoof H; Rosseneu M Nature; 1986 Oct 23-29; 323(6090):738-42. PubMed ID: 3095664 [TBL] [Abstract][Full Text] [Related]
11. Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice. Pennings M; Hildebrand RB; Ye D; Kunne C; Van Berkel TJ; Groen AK; Van Eck M Cardiovasc Res; 2007 Oct; 76(1):175-83. PubMed ID: 17560559 [TBL] [Abstract][Full Text] [Related]
12. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Paulson KE; Zhu SN; Chen M; Nurmohamed S; Jongstra-Bilen J; Cybulsky MI Circ Res; 2010 Feb; 106(2):383-90. PubMed ID: 19893012 [TBL] [Abstract][Full Text] [Related]
13. Conformationally specific enhancement of receptor-mediated LDL binding and internalization by peptide models of a conserved anionic N-terminal domain of human apolipoprotein E. Braddock DT; Mercurius KO; Subramanian RM; Dominguez SR; Davies PF; Meredith SC Biochemistry; 1996 Nov; 35(44):13975-84. PubMed ID: 8909295 [TBL] [Abstract][Full Text] [Related]
15. Functional effects of eggs, naturally enriched with conjugated linoleic acid, on the blood lipid profile, development of atherosclerosis and composition of atherosclerotic plaque in apolipoprotein E and low-density lipoprotein receptor double-knockout mice (apoE/LDLR-/-). Franczyk-Zarów M; Kostogrys RB; Szymczyk B; Jawień J; Gajda M; Cichocki T; Wojnar L; Chlopicki S; Pisulewski PM Br J Nutr; 2008 Jan; 99(1):49-58. PubMed ID: 17678565 [TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men. Sjögren P; Fredrikson GN; Rosell M; de Faire U; Hamsten A; Nilsson J; Hellenius ML; Fisher RM Metabolism; 2008 Mar; 57(3):362-6. PubMed ID: 18249208 [TBL] [Abstract][Full Text] [Related]
17. Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies. George J; Afek A; Gilburd B; Levy Y; Blank M; Kopolovic J; Harats D; Shoenfeld Y Lupus; 1997; 6(9):723-9. PubMed ID: 9412988 [TBL] [Abstract][Full Text] [Related]
18. Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic apo E (-/-) mice. Chyu KY; Zhao X; Reyes OS; Babbidge SM; Dimayuga PC; Yano J; Cercek B; Fredrikson GN; Nilsson J; Shah PK Biochem Biophys Res Commun; 2005 Dec; 338(4):1982-9. PubMed ID: 16288717 [TBL] [Abstract][Full Text] [Related]
19. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse. Romeo GR; Moulton KS; Kazlauskas A Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372 [TBL] [Abstract][Full Text] [Related]
20. Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis. Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Hough G; Wagner A; Nakamura K; Garber DW; Datta G; Segrest JP; Hama S; Fogelman AM Curr Opin Investig Drugs; 2003 Sep; 4(9):1100-4. PubMed ID: 14582455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]